ImmunologybioRxivPreprint
Preclinical Efficacy of IMM-BCP-01, a Highly Active Patient-Derived Anti-SARS-CoV-2 Antibody Cocktail
P. A. Nikitin, J. M. DiMuzio, J. P. Dowling…·M. K. Robinson
The paper identifies and characterizes an antibody cocktail, IMM-BCP-01, that neutralizes SARS-CoV-2 variants in vitro and inhibits infection in vivo through Spike Trimer dissociation and effector responses.
DOI 10.1101/2021.10.18.464900